"It's troubling that President Trump's new FDA commissioner has refused to acknowledge mifepristone's longstanding record of overwhelming safety and efficacy," Liz Wagner, senior federal policy counsel at the Center for Reproductive Rights, told HuffPost. "And it's even more troubling that a deeply flawed, non-peer-reviewed 'study' was released by an anti-abortion group immediately after Dr. Makary told a reporter that the FDA may act on 'a real signal' on mifepristone." …
No comments:
Post a Comment